Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13312-020-2026-0 http://scihub22266oqcxt.onion/10.1007/s13312-020-2026-0 32788432!7678602!32788432     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Indian+Pediatr 2020 ; 57 (11): 1015-1019 Nephropedia Template TP {{tp|p=32788432|t=2020. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India |pdf=|usr=}}{{32788432}} gab.com Text Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India JO: Indian Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=32788432 #FOAvip OBJECTIVE: We describe the presentation, treatment and outcome of children with multisystem inflammatory syndrome with COVID-19 (MIS-C) in Mumbai metropolitan area in India. METHOD: This is an observational study conducted at four tertiary hospitals in Mumbai. Parameters including demographics, symptomatology, laboratory markers, medications and outcome were obtained from patient hospital records and analyzed in patients treated for MIS-C (as per WHO criteria) from 1 May, 2020 to 15 July, 2020. RESULTS: 23 patients (11 males) with median (range) age of 7.2 (0.8-14) years were included. COVID-19 RT-PCR or antibody was positive in 39.1% and 30.4%, respectively; 34.8% had a positive contact. 65% patients presented in shock; these children had a higher age (P=0.05), and significantly higher incidence of myocarditis with elevated troponin, NT pro BNP and left ventri-cular dysfunction, along with significant neutrophilia and lympho-penia, as compared to those without shock. Coronary artery dilation was seen in 26% patients overall. Steroids were used most commonly for treatment (96%), usually along with intra-venous immunoglobulin (IVIg) (65%). Outcome was good with only one death. CONCLUSION: Initial data on MIS-C from India is presented. Further studies and longer surveillance of patients with MIS-C are required to improve our diagnostic, treatment and surveillance criteria. Twit Text FOAVip Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India ????Indian Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=32788432 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32788432 #FOAvip English Wikipedia <ref>{{Cite pmid|32788432}}</ref> Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India #MMPMID32788432 Jain S; Sen S; Lakshmivenkateshiah S; Bobhate P; Venkatesh S; Udani S; Shobhavat L; Andankar P; Karande T; Kulkarni S Indian Pediatr 2020[Nov]; 57 (11): 1015-1019 PMID32788432show ga OBJECTIVE: We describe the presentation, treatment and outcome of children with multisystem inflammatory syndrome with COVID-19 (MIS-C) in Mumbai metropolitan area in India. METHOD: This is an observational study conducted at four tertiary hospitals in Mumbai. Parameters including demographics, symptomatology, laboratory markers, medications and outcome were obtained from patient hospital records and analyzed in patients treated for MIS-C (as per WHO criteria) from 1 May, 2020 to 15 July, 2020. RESULTS: 23 patients (11 males) with median (range) age of 7.2 (0.8-14) years were included. COVID-19 RT-PCR or antibody was positive in 39.1% and 30.4%, respectively; 34.8% had a positive contact. 65% patients presented in shock; these children had a higher age (P=0.05), and significantly higher incidence of myocarditis with elevated troponin, NT pro BNP and left ventri-cular dysfunction, along with significant neutrophilia and lympho-penia, as compared to those without shock. Coronary artery dilation was seen in 26% patients overall. Steroids were used most commonly for treatment (96%), usually along with intra-venous immunoglobulin (IVIg) (65%). Outcome was good with only one death. CONCLUSION: Initial data on MIS-C from India is presented. Further studies and longer surveillance of patients with MIS-C are required to improve our diagnostic, treatment and surveillance criteria. |Adolescent[MESH] |Biomarkers/blood[MESH] |COVID-19/*diagnosis/epidemiology/therapy[MESH] |Child[MESH] |Child, Preschool[MESH] |Female[MESH] |Glucocorticoids/therapeutic use[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |India/epidemiology[MESH] |Infant[MESH] |Lymphopenia/etiology[MESH] |Male[MESH] |Myocarditis/etiology[MESH] |Natriuretic Peptide, Brain/blood[MESH] |Neutrophils/metabolism[MESH] |Peptide Fragments/blood[MESH] |Shock/etiology[MESH] |Systemic Inflammatory Response Syndrome/*diagnosis/epidemiology/therapy[MESH] |Troponin/blood[MESH]Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai,(epmc).pdf DeepDyve Pubget Overpricing